Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 21, 2017EBioMedicineOpen Access

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development

View Full Paper
Ask AI
Bookmark
Share

Authors

IRIris RajmanNovartis (Japan)LKLaura KnappUnilever (United Kingdom)TMThomas M. MorganVanderbilt University Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rajman et al. (2017) studied this question.

synapsesocial.com/papers/69f8281aa66f59c2557a2fa1https://doi.org/10.1016/j.ebiom.2017.02.017
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz2005 · 269 citations
  2. 2The African Genome Variation Project shapes medical genetics in Africa2014 · 701 citations
  3. 3Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants2013 · 455 citations
  4. 4A missense mutation in growth differentiation factor 9 (GDF9) is strongly associated with litter size in sheep2013 · 258 citations
  5. 5Comparison of genome sequencing and clinical genotyping for pharmacogenes2016 · 53 citations